WHO essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveys.
Suboptimal medicine use is a global public health problem. For 35 years the World Health Organization (WHO) has promoted essential medicines policies to improve quality use of medicines (QUM), but evidence of their effectiveness is lacking, and uptake by countries remains low. Our objective was to d...
Main Authors: | Kathleen Anne Holloway, David Henry |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-09-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC4165598?pdf=render |
Similar Items
-
The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics.
by: Kathleen Anne Holloway, et al.
Published: (2016-01-01) -
Identifying the most effective essential medicines policies for quality use of medicines: A replicability study using three World Health Organisation data-sets.
by: Kathleen Anne Holloway, et al.
Published: (2020-01-01) -
An analysis on rational use and affordability of medicine after the implementation of National Essential Medicines Policy and Zero Mark-up Policy in Hangzhou, China.
by: Wenhui Mao, et al.
Published: (2019-01-01) -
NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions
by: Mariachiara Di Cesare, et al.
Published: (2020-10-01) -
Promoting quality use of medicines in South-East Asia: reports from country situational analyses
by: Kathleen Anne Holloway, et al.
Published: (2018-07-01)